Brook Gram, PA
Physician Assistant · Beloit, OHNPI 1740321090
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $43,553 of the $52,399 with a category attached, or 83.1%. Medtronic accounts for 72.9% of it on its own, with 35 other manufacturers making up the rest. Reporting peaked in 2023 at $18,583 and has fallen 92.5% since, to $1,390 in 2025. Among physician assistant clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 505 payments — averaging $103.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$38K
- Insulet Corporation$6K
- AbbVie$2K
- Lilly USA, LLC$1K
- Novo Nordisk$700
- Corcept Therapeutics$566
- plus $4K from 30 others
What the payments were for
- Speaking & faculty fees$43,55383%
- Travel & lodging$2430%
- Food & beverage$8,49516%
- Education$1080%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 15 | $38,210 |
| Insulet Corporation | 26 | $5,634 |
| AbbVie | 93 | $1,806 |
| Lilly USA, LLC | 57 | $1,077 |
| Novo Nordisk | 54 | $700 |
| Corcept Therapeutics | 30 | $566 |
| Amgen | 29 | $541 |
| Bayer | 13 | $416 |
| Amarin Pharma, Inc. | 33 | $389 |
| Johnson & Johnson | 14 | $340 |
| Boehringer Ingelheim | 22 | $329 |
| UCB, Inc. | 9 | $295 |
| Sanofi | 11 | $271 |
| Sanofi-aventis U.S. LLC | 18 | $264 |
| E.r. Squibb & Sons, L.L.C. | 11 | $228 |
| Incyte Corporation | 11 | $190 |
| Novartis | 11 | $177 |
| AstraZeneca | 6 | $132 |
| Xeris Pharmaceuticals, Inc. | 7 | $128 |
| Regeneron Healthcare Solutions, Inc. | 2 | $111 |
| Halozyme Inc | 4 | $81 |
| Merck | 5 | $76 |
| Esperion Therapeutics, Inc. | 4 | $67 |
| Arbor Pharmaceuticals, Inc. | 2 | $56 |
| Recordati_rare_diseases_inc. | 3 | $54 |
| Dexcom, Inc. | 2 | $44 |
| Pfizer | 2 | $36 |
| Amneal Pharmaceuticals LLC | 2 | $33 |
| Clarus Therapeutics Inc. | 2 | $30 |
| Sun Pharmaceutical Industries Inc. | 1 | $21 |
| Ultragenyx Pharmaceutical Inc. | 1 | $21 |
| Organon | 1 | $19 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $15 |
| Galderma Laboratories, L.p. | 1 | $14 |
| Endo Pharmaceuticals Inc. | 1 | $14 |
| Tandem Diabetes Care, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MINIMED 770G$15,685
- MINIMED 780G$12,792
- Minimed 770G System$9,716
- Omnipod$5,300
- Kerendia$106
How this compares
$52,399 in reported general payments places this provider in the 95th percentile of 4,098 physician assistant providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 101 | $139,901 |
| JardianceEmpagliflozin | 104 | $90,136 |
| TrulicityDulaglutide | 44 | $65,237 |
| Dupixent PenDupilumab | 16 | $60,656 |
| Tresiba Flextouch U-200Insulin Degludec | 34 | $48,154 |
| VascepaIcosapent Ethyl | 51 | $33,083 |
| FarxigaDapagliflozin Propanediol | 26 | $32,368 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 33 | $31,417 |
| Humulin R U-500 KwikpenInsulin Regular, Human | 20 | $29,963 |
| Omnipod Dash Pods (Gen 4)Insulin Pump Cart,cont Inf,bt | 14 | $27,224 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 20 | $25,173 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 18 | $21,408 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 25 | $20,999 |
| Tresiba Flextouch U-100Insulin Degludec | 22 | $17,726 |
| TradjentaLinagliptin | 11 | $15,618 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Novolog | $700 | $148,168113 claims |
| Boehringer IngelheimJardiance, Tradjenta, Glyxambi | $329 | $119,238127 claims |
| Lilly USA, LLCTrulicity, Humalog | $1,077 | $72,52769 claims |
| AstraZenecaFarxiga | $132 | $32,36826 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33, Lantus | $264 | $25,59329 claims |
| MerckJanuvia | $76 | $13,49516 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $33 | $2,680274 claims |
| AbbVieSynthroid | $1,806 | $2,04630 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,098 physician assistant providers in Ohio.
Other physician assistant in Beloit
- Steven WurzelbacherCincinnati$309K
- Emily AnkromDayton$192K
- Amanda MaggartWorthington$164K
- Megan SevillaMayfield Heights$132K
- Erin StrculaBelpre$106K
- Sarah LaubNew Albany$100K
- Jessica RhominskiCanal Winchester$78K
- Alison FleigToledo$48K
- Alicia PerkinsColumbus$44K
- Julie WestColumbus$41K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.